14.55
price up icon2.97%   0.42
pre-market  Pre-mercato:  14.55  
loading

Dyne Therapeutics Inc Azioni (DYN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
2.17%
69.16
67.69 62.27 66.74 45.46
Operating Income/Loss
2.17%
-69.16
-67.69 -62.27 -66.74 -45.46
Income/Loss From Continuing Operations Before Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Income/Loss From Continuing Operations After Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Net Income/Loss
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Diluted Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):